MAX86178ENJ+

Analog Front End (AFE) Overview

The MAX86178ENJ+T is a clinical-grade analog front-end (AFE) integrating three distinct measurement systems: optical photoplethysmography (PPG), electrocardiogram (ECG), and bioimpedance (BioZ). This single-chip solution enables the simultaneous acquisition of four vital signs, including ECG, heart rate, blood oxygen saturation (SpO2), and respiratory rate. The device supports synchronized timing between optical PPG and ECG signals to facilitate advanced health metrics. Designed for remote patient monitoring applications, it consolidates multiple subsystems into a compact 2.6mm x 2.8mm package, reducing board space compared to discrete designs.

Analog Front End (AFE) Feature Summary

• Integrates optical PPG, single-lead ECG, and BioZ subsystems on one chip
• Simultaneously measures ECG, heart rate, SpO2, and respiratory rate
• Supports synchronized optical PPG and ECG timing for derived health indicators
• Configurable options optimize battery life for specific application scenarios

Analog Front End (AFE) Applications

• Remote patient monitoring (RPM) devices
• Wearable medical chest patches
• Chronic disease management systems
• Infectious disease diagnostic tools

Analog Front End (AFE) Part Context

Analog Devices acquired Maxim Integrated, merging their product portfolios. The MAX86178 represents a convergence of these technologies, targeting the healthcare market with sensor fusion capabilities. It replaces traditional discrete component solutions with a unified silicon approach, supporting the industry shift toward smaller, lower-power wearable health monitors.

Analog Front End (AFE) Replacement Considerations

Verify pinout compatibility and firmware configuration when substituting. Ensure the replacement component supports the required triple-system integration (PPG, ECG, BioZ) and maintains clinical-grade accuracy standards for vital sign measurement.